Alexei Goraltchouk
Directeur des opérations chez Remedium Bio, Inc.
Profil
Alexei Goraltchouk is currently the Chief Operating Officer & Director at Remedium Bio, Inc. Previously, he worked as the Senior VP-Operations & Project Management at Anika Therapeutics, Inc. from 2018 to 2021 and as the Vice President-Operations at Avedro, Inc. He holds a graduate degree and an MBA from Indiana University and an undergraduate and graduate degree from the University of Toronto.
Postes actifs de Alexei Goraltchouk
| Sociétés | Poste | Début |
|---|---|---|
Remedium Bio, Inc.
 Remedium Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Remedium Bio, Inc. is a biotechnology company that focuses on the development of curative treatments. The company is based in Needham, MA. The CEO of the company is Francesco J. Luppino. | Directeur des opérations | - |
Anciens postes connus de Alexei Goraltchouk
| Sociétés | Poste | Fin |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Directeur des opérations | 01/01/2021 |
| AVEDRO, INC. | Directeur des opérations | - |
Formation de Alexei Goraltchouk
| Indiana University | Graduate Degree |
| University of Toronto | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Remedium Bio, Inc.
Remedium Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Remedium Bio, Inc. is a biotechnology company that focuses on the development of curative treatments. The company is based in Needham, MA. The CEO of the company is Francesco J. Luppino. | Commercial Services |
